INDP

Indaptus Therapeutics, Inc. - Common Stock (INDP)

About Indaptus Therapeutics, Inc. - Common Stock (INDP)

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

Details

Daily high

$2.50

Daily low

$2.14

Price at open

$2.17

52 Week High

$47.60

52 Week Low

$1.65

Market cap

4.4M

Dividend yield

0.00%

Volume

86,756

Avg. volume

42,251

P/E ratio

-.08

Indaptus Therapeutics, Inc. - Common Stock News